2nd Quarter - Amendment

BUCHANAN INGERSOLL & ROONEY PC for VAXXINITY, INC.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2022 $20,000 Replaced
2nd Quarter - Amendment (this page) Jul 20, 2022 $50,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
EMILY ELAINE COYLE Legislative Director, Rep. Debbie Wasserman Schultz
MICHAEL P STRAZZELLA —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Aerospace AER

Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
EMILY ELAINE COYLE Legislative Director, Rep. Debbie Wasserman Schultz
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Aeronautics & Space Administration (NASA)

Defense DEF

Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
EMILY ELAINE COYLE Legislative Director, Rep. Debbie Wasserman Schultz
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD)

Manufacturing MAN

Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
EMILY ELAINE COYLE Legislative Director, Rep. Debbie Wasserman Schultz
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Medical/Disease Research/Clinical Labs MED

Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
EMILY ELAINE COYLE Legislative Director, Rep. Debbie Wasserman Schultz
MICHAEL P STRAZZELLA —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Veterans VET

Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
EMILY ELAINE COYLE Legislative Director, Rep. Debbie Wasserman Schultz
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.